(Q28204939)

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Current Opinion in Pediatrics

14 March 2024

published in

0 references

volume

15

0 references

issue

5

0 references

page(s)

476-82

0 references

cites work

Correlates of ADHD among children in pediatric and psychiatric clinics.

1

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youths with ADHD.

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Attention-deficit/hyperactivity disorder and comorbidity

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Correlates of comorbid psychopathology in children with ADHD.

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Treatment of ADHD in children with tics: a randomized controlled trial

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Depression in attention deficit hyperactivity disorder (ADHD) children: "true" depression or demoralization?

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

14 March 2024

Study 329

19

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

14 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Is comorbidity with ADHD a marker for juvenile-onset mania?

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children

14 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype.

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Journal of the American Academy of Child and Adolescent Psychiatry

14 March 2024

27

159

918

State

2002

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Conditioning and sensitisation in the longitudinal course of affective illness

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset

14 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young

14 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study

14 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder

14 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Does comorbid attention-deficit/hyperactivity disorder impact the clinical expression of pediatric obsessive-compulsive disorder?

14 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Response to methylphenidate in children with ADHD and comorbid anxiety

14 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings

14 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00008480-200310000-00006

14 March 2024

Identifiers